Not Rated
|
Fund Size
(0% of Investment in Category)
|
Expense Ratio
(0.28% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 14-Nov-25 | 9968.10 | -0.32% | - | -0.20% | 252/352 |
| 1 Month | 20-Oct-25 | 9880.80 | -1.19% | - | 0.31% | 316/350 |
| 3 Month | 21-Aug-25 | 10060.60 | 0.61% | - | 2.66% | 307/341 |
| Since Inception | 20-Jun-25 | 10521.70 | 5.22% | 12.81% | 9.92% | 268/344 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| No Data Found | |||||
Please check with your Tax Advisor.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 25.2 | 18.15% | 0.48% | 18.51% (Jul 2025) | 0% (Nov 2024) | 14.89 k | 557.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 12.1 | 8.72% | 1.12% | 8.73% (Jun 2025) | 0% (Nov 2024) | 1.79 k | 67.00 |
| Max Healthcare Institute Ltd. | Hospital | 12.1 | 8.69% | -0.02% | 9.58% (Jun 2025) | 0% (Nov 2024) | 10.50 k | 392.00 |
| Cipla Ltd. | Pharmaceuticals | 11.9 | 8.60% | -0.29% | 9.32% (Aug 2025) | 0% (Nov 2024) | 7.95 k | 298.00 |
| Apollo Hospitals Enterprises Ltd. | Hospital | 11 | 7.90% | 0.03% | 8.02% (Aug 2025) | 0% (Nov 2024) | 1.43 k | 53.00 |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 10.3 | 7.43% | -0.41% | 8% (Aug 2025) | 0% (Nov 2024) | 8.61 k | 322.00 |
| Fortis Healthcare Ltd. | Hospital | 7.5 | 5.43% | 0.12% | 5.43% (Oct 2025) | 0% (Nov 2024) | 7.36 k | 276.00 |
| Lupin Ltd. | Pharmaceuticals | 6.7 | 4.84% | -0.02% | 4.86% (Sep 2025) | 0% (Nov 2024) | 3.42 k | 128.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 5.3 | 3.79% | -0.17% | 3.96% (Sep 2025) | 0% (Nov 2024) | 1.48 k | 55.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 5.2 | 3.77% | 0.33% | 3.77% (Oct 2025) | 0% (Nov 2024) | 5.49 k | 205.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.83% |
| Net Receivables | Net Receivables | -0.81% |
Ratios calculated on daily returns for last 3 years (Updated as on 01st January, 1970)
No data available. Ratios are only available for the funds which are 3 years old.
Out of 64 mutual fund schemes offered by this AMC, 6 is/are ranked 5 * , 8 is/are ranked 4 * , 11 is/are ranked 3 * , and 39 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| DSP Midcap Fund - Direct Plan - Growth | 3 | 19609.01 | 0.23 | 0.92 | 6.24 | 6.93 | 21.05 |
| DSP Liquidity Fund - Direct Plan - Growth | 3 | 19054.79 | 0.50 | 1.47 | 3.02 | 6.74 | 7.08 |
| DSP ELSS Tax Saver Fund - Direct Plan - Growth | 5 | 17241.31 | 1.59 | 3.79 | 4.55 | 9.61 | 20.94 |
| DSP Small Cap Fund - Direct Plan - Growth | 3 | 16867.93 | 0.90 | -0.81 | 5.27 | 4.11 | 21.42 |
| DSP Large & Mid Cap Fund - Direct Plan - Growth | 4 | 16530.07 | 1.34 | 3.22 | 4.57 | 9.00 | 21.54 |
| DSP Flexi Cap Fund - Direct Plan - Growth | 3 | 12197.68 | 0.07 | 2.66 | 3.76 | 7.07 | 18.86 |
| DSP Aggressive Hybrid Fund - Direct Plan - Growth | 4 | 11909.72 | -0.18 | 1.52 | 2.09 | 8.46 | 17.33 |
| DSP Savings Fund - Direct Plan - Growth | 4 | 7524.16 | 0.54 | 1.54 | 3.30 | 7.39 | 7.49 |
| DSP Large Cap Fund - Direct Plan - Growth | 5 | 6933.59 | 0.60 | 2.99 | 3.61 | 9.88 | 19.03 |
| DSP Arbitrage fund - Direct Plan - Growth | 3 | 6447.92 | 0.61 | 1.56 | 3.23 | 6.91 | 7.70 |